ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2018

A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss.

Maria J Pereira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.